XHALVISS Trademark

Trademark Overview


On Thursday, November 11, 2021, a trademark application was filed for XHALVISS with the United States Patent and Trademark Office. The USPTO has given the XHALVISS trademark a serial number of 97120571. The federal status of this trademark filing is REGISTERED as of Tuesday, January 10, 2023. This trademark is owned by Glaxo Group Limited. The XHALVISS trademark is filed in the Pharmaceutical Products category with the following description:

(Based on 44(e)) Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
xhalviss

General Information


Serial Number97120571
Word MarkXHALVISS
Filing DateThursday, November 11, 2021
Status700 - REGISTERED
Status DateTuesday, January 10, 2023
Registration Number6946471
Registration DateTuesday, January 10, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 25, 2022

Trademark Statements


Goods and Services(Based on 44(e)) Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
Translation of Words in MarkThe word(s) "XHALVISS" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 18, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Monday, October 9, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 9, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 9, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 9, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 9, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 10, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 10, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, October 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 25, 2022PUBLISHED FOR OPPOSITION
Wednesday, October 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, September 19, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 19, 2022DATA MODIFICATION COMPLETED
Thursday, July 28, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, July 28, 2022LETTER OF SUSPENSION E-MAILED
Thursday, July 28, 2022SUSPENSION LETTER WRITTEN
Tuesday, July 26, 2022DATA MODIFICATION COMPLETED
Tuesday, July 26, 2022ASSIGNED TO LIE
Tuesday, July 26, 2022ASSIGNED TO EXAMINER
Thursday, November 18, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 15, 2021NEW APPLICATION ENTERED